Evidence map›Paper›PMID 41089878›Full record

ReviewJournal of medical extended reality2025

Design and Refinement of CyberCell

Aimee K Hildenbrand, Melanie Pitone, Benjamin Bear, Corinna L Schultz, Sherman Finch, Danielle Morley, Stephanie Hubbard, Alyssa Decino, Melissa A Alderfer, Lori E Crosby and 1 more

Abstract readReview
In one paragraph

Review in Journal of medical extended reality, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aimee K HildenbrandCenter for Healthcare Delivery Science, Nemours Children's Health, Wilmington, Delaware, USA.ORCID https://orcid.org/0000-0003-0147-3232
Melanie PitoneOnXR, Inc., Westminster, Maryland, USA.
Benjamin BearCenter for Healthcare Delivery Science, Nemours Children's Health, Wilmington, Delaware, USA.
Corinna L SchultzDepartment of Pediatrics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Sherman FinchCollege of Art and Media, Sam Houston State University, Huntsville, Texas, USA.
Danielle MorleyLisa Dean Moseley Foundation Institute for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, Delaware, USA.
Stephanie HubbardLisa Dean Moseley Foundation Institute for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, Delaware, USA.
Alyssa DecinoCenter for Healthcare Delivery Science, Nemours Children's Health, Wilmington, Delaware, USA.
Melissa A AlderferCenter for Healthcare Delivery Science, Nemours Children's Health, Wilmington, Delaware, USA.
Lori E CrosbyDivision of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Fredric FreemanOnXR, Inc., Westminster, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For people living with sickle cell disease (SCD), the risk for disease complications and premature death rises sharply in adolescence and young adulthood, when chronic organ damage is compounded by reduced preventive care. To make informed health care decisions, adolescents and young adults (AYAs) require effective education about their health condition and treatment options. We aimed to systematically design and develop a user-centered, evidence-based virtual reality (VR) health education program to optimize the use of SCD therapies among AYAs with SCD. We engaged a diverse team including AYAs with SCD and their caregivers, multidisciplinary SCD clinicians and researchers, patient education specialists, and health technology developers. Stakeholder meetings and codesign workshops were used to evaluate end-user and implementer needs, develop low- and high-fidelity prototypes of the VR program, and draft an implementation plan. Subsequently, iterative cycles of usability testing were conducted with 17 AYAs with SCD (

Indexed as

immersivepatient educationshared decision-makingsickle cell diseaseusabilityvirtual reality

Identifiers

PMID41089878
PMCPMC12516198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.